Global Influenza Medication Market Insights, Forecast to 2025

Date: May 08 2019
|
QYRESEARCH
|
Number of Pages: 111
|
Alternate Text Alternate Text Alternate Text Alternate Text

Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. High growth of the global influenza medication market is due to unmet medical needs within the annual influenza epidemics along with strong R&D focus resulting in new and advanced treatments and drugs, and increasing demand due to government stockpiling.
In term of distribution channels, global influenza medications market is divided into hospitals, clinics, pharmacies and others. Incidence and prevalence of flu are gradually increasing across the globe. Of these, the pharmacies segment held dominance in 2017. Through the course of the forecast period, growth run witnessed by the segment is likely to remain steady due to the mushrooming pharmacy stores around the world. Besides this, the market is likely to witness lucrative prospects in the hospitals segment.
The global Influenza Medication market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Influenza Medication market based on company, product type, end user and key regions.

This report studies the global market size of Influenza Medication in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Influenza Medication in these regions.
This research report categorizes the global Influenza Medication market by top players/brands, region, type and end user. This report also studies the global Influenza Medication market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Daiichi Sankyo Company
GlaxoSmithKline
Natco Pharma
F. Hoffmann-La Roche
Teva Pharmaceutical
Sandoz International GmbH (Novartis AG)
Sun Pharmaceutical Industries
Mylan

Market size by Product
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Other
Market size by End User
Hospitals
Clinics
Pharmacies
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Influenza Medication market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Influenza Medication market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Influenza Medication companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Influenza Medication submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Influenza Medication are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Influenza Medication market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents
1 Study Coverage
    1.1 Influenza Medication Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
           1.4.1 Global Influenza Medication Market Size Growth Rate by Product
           1.4.2 Zanamivir
           1.4.3 Oseltamivir
           1.4.4 Peramivir
           1.4.5 Amantadine
           1.4.6 Rimantadine
           1.4.7 Inosine
           1.4.8 Other
    1.5 Market by End User
           1.5.1 Global Influenza Medication Market Size Growth Rate by End User
           1.5.2 Hospitals
           1.5.3 Clinics
           1.5.4 Pharmacies
           1.5.5 Others
    1.6 Study Objectives
    1.7 Years Considered
2 Executive Summary
    2.1 Global Influenza Medication Market Size
           2.1.1 Global Influenza Medication Revenue 2014-2025
           2.1.2 Global Influenza Medication Sales 2014-2025
    2.2 Influenza Medication Growth Rate by Regions
           2.2.1 Global Influenza Medication Sales by Regions
           2.2.2 Global Influenza Medication Revenue by Regions
3 Breakdown Data by Manufacturers
    3.1 Influenza Medication Sales by Manufacturers
           3.1.1 Influenza Medication Sales by Manufacturers
           3.1.2 Influenza Medication Sales Market Share by Manufacturers
           3.1.3 Global Influenza Medication Market Concentration Ratio (CR5 and HHI)
    3.2 Influenza Medication Revenue by Manufacturers
           3.2.1 Influenza Medication Revenue by Manufacturers (2014-2019)
           3.2.2 Influenza Medication Revenue Share by Manufacturers (2014-2019)
    3.3 Influenza Medication Price by Manufacturers
    3.4 Influenza Medication Manufacturing Base Distribution, Product Types
           3.4.1 Influenza Medication Manufacturers Manufacturing Base Distribution, Headquarters
           3.4.2 Manufacturers Influenza Medication Product Type
           3.4.3 Date of International Manufacturers Enter into Influenza Medication Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
    4.1 Global Influenza Medication Sales by Product
    4.2 Global Influenza Medication Revenue by Product
    4.3 Influenza Medication Price by Product
5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Influenza Medication Breakdown Data by End User
6 North America
    6.1 North America Influenza Medication by Countries
           6.1.1 North America Influenza Medication Sales by Countries
           6.1.2 North America Influenza Medication Revenue by Countries
           6.1.3 United States
           6.1.4 Canada
           6.1.5 Mexico
    6.2 North America Influenza Medication by Product
    6.3 North America Influenza Medication by End User
7 Europe
    7.1 Europe Influenza Medication by Countries
           7.1.1 Europe Influenza Medication Sales by Countries
           7.1.2 Europe Influenza Medication Revenue by Countries
           7.1.3 Germany
           7.1.4 France
           7.1.5 UK
           7.1.6 Italy
           7.1.7 Russia
    7.2 Europe Influenza Medication by Product
    7.3 Europe Influenza Medication by End User
8 Asia Pacific
    8.1 Asia Pacific Influenza Medication by Countries
           8.1.1 Asia Pacific Influenza Medication Sales by Countries
           8.1.2 Asia Pacific Influenza Medication Revenue by Countries
           8.1.3 China
           8.1.4 Japan
           8.1.5 Korea
           8.1.6 India
           8.1.7 Australia
           8.1.8 Indonesia
           8.1.9 Malaysia
           8.1.10 Philippines
           8.1.11 Thailand
           8.1.12 Vietnam
           8.1.13 Singapore
    8.2 Asia Pacific Influenza Medication by Product
    8.3 Asia Pacific Influenza Medication by End User
9 Central & South America
    9.1 Central & South America Influenza Medication by Countries
           9.1.1 Central & South America Influenza Medication Sales by Countries
           9.1.2 Central & South America Influenza Medication Revenue by Countries
           9.1.3 Brazil
    9.2 Central & South America Influenza Medication by Product
    9.3 Central & South America Influenza Medication by End User
10 Middle East and Africa
    10.1 Middle East and Africa Influenza Medication by Countries
           10.1.1 Middle East and Africa Influenza Medication Sales by Countries
           10.1.2 Middle East and Africa Influenza Medication Revenue by Countries
           10.1.3 GCC Countries
           10.1.4 Turkey
           10.1.5 Egypt
           10.1.6 South Africa
    10.2 Middle East and Africa Influenza Medication by Product
    10.3 Middle East and Africa Influenza Medication by End User
11 Company Profiles
    11.1 Daiichi Sankyo Company
           11.1.1 Daiichi Sankyo Company Company Details
           11.1.2 Company Business Overview
           11.1.3 Daiichi Sankyo Company Influenza Medication Sales, Revenue and Gross Margin (2014-2019)
           11.1.4 Daiichi Sankyo Company Influenza Medication Products Offered
           11.1.5 Daiichi Sankyo Company Recent Development
    11.2 GlaxoSmithKline
           11.2.1 GlaxoSmithKline Company Details
           11.2.2 Company Business Overview
           11.2.3 GlaxoSmithKline Influenza Medication Sales, Revenue and Gross Margin (2014-2019)
           11.2.4 GlaxoSmithKline Influenza Medication Products Offered
           11.2.5 GlaxoSmithKline Recent Development
    11.3 Natco Pharma
           11.3.1 Natco Pharma Company Details
           11.3.2 Company Business Overview
           11.3.3 Natco Pharma Influenza Medication Sales, Revenue and Gross Margin (2014-2019)
           11.3.4 Natco Pharma Influenza Medication Products Offered
           11.3.5 Natco Pharma Recent Development
    11.4 F. Hoffmann-La Roche
           11.4.1 F. Hoffmann-La Roche Company Details
           11.4.2 Company Business Overview
           11.4.3 F. Hoffmann-La Roche Influenza Medication Sales, Revenue and Gross Margin (2014-2019)
           11.4.4 F. Hoffmann-La Roche Influenza Medication Products Offered
           11.4.5 F. Hoffmann-La Roche Recent Development
    11.5 Teva Pharmaceutical
           11.5.1 Teva Pharmaceutical Company Details
           11.5.2 Company Business Overview
           11.5.3 Teva Pharmaceutical Influenza Medication Sales, Revenue and Gross Margin (2014-2019)
           11.5.4 Teva Pharmaceutical Influenza Medication Products Offered
           11.5.5 Teva Pharmaceutical Recent Development
    11.6 Sandoz International GmbH (Novartis AG)
           11.6.1 Sandoz International GmbH (Novartis AG) Company Details
           11.6.2 Company Business Overview
           11.6.3 Sandoz International GmbH (Novartis AG) Influenza Medication Sales, Revenue and Gross Margin (2014-2019)
           11.6.4 Sandoz International GmbH (Novartis AG) Influenza Medication Products Offered
           11.6.5 Sandoz International GmbH (Novartis AG) Recent Development
    11.7 Sun Pharmaceutical Industries
           11.7.1 Sun Pharmaceutical Industries Company Details
           11.7.2 Company Business Overview
           11.7.3 Sun Pharmaceutical Industries Influenza Medication Sales, Revenue and Gross Margin (2014-2019)
           11.7.4 Sun Pharmaceutical Industries Influenza Medication Products Offered
           11.7.5 Sun Pharmaceutical Industries Recent Development
    11.8 Mylan
           11.8.1 Mylan Company Details
           11.8.2 Company Business Overview
           11.8.3 Mylan Influenza Medication Sales, Revenue and Gross Margin (2014-2019)
           11.8.4 Mylan Influenza Medication Products Offered
           11.8.5 Mylan Recent Development
12 Future Forecast
    12.1 Influenza Medication Market Forecast by Regions
           12.1.1 Global Influenza Medication Sales Forecast by Regions 2019-2025
           12.1.2 Global Influenza Medication Revenue Forecast by Regions 2019-2025
    12.2 Influenza Medication Market Forecast by Product
           12.2.1 Global Influenza Medication Sales Forecast by Product 2019-2025
           12.2.2 Global Influenza Medication Revenue Forecast by Product 2019-2025
    12.3 Influenza Medication Market Forecast by End User
    12.4 North America Influenza Medication Forecast
    12.5 Europe Influenza Medication Forecast
    12.6 Asia Pacific Influenza Medication Forecast
    12.7 Central & South America Influenza Medication Forecast
    12.8 Middle East and Africa Influenza Medication Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Influenza Medication Customers
    14.3 Sales Channels Analysis
           14.3.1 Sales Channels
           14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
    16.1 Research Methodology
           16.1.1 Methodology/Research Approach
           16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables and Figures
Figure Influenza Medication Product Picture
Table Influenza Medication Market Segments
Table Key Manufacturers Influenza Medication Covered
Table Global Influenza Medication Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Influenza Medication Sales Market Share by Product 2014-2025
Figure Zanamivir Product Picture
Table Major Manufacturers of Zanamivir
Figure Oseltamivir Product Picture
Table Major Manufacturers of Oseltamivir
Figure Peramivir Product Picture
Table Major Manufacturers of Peramivir
Figure Amantadine Product Picture
Table Major Manufacturers of Amantadine
Figure Rimantadine Product Picture
Table Major Manufacturers of Rimantadine
Figure Inosine Product Picture
Table Major Manufacturers of Inosine
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Influenza Medication Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Pharmacies
Figure Others
Figure Influenza Medication Report Years Considered
Figure Global Influenza Medication Market Size 2014-2025 (Million US$)
Figure Global Influenza Medication Sales 2014-2025 (K Units)
Table Global Influenza Medication Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Influenza Medication Sales by Regions 2014-2019 (K Units)
Table Global Influenza Medication Sales Market Share by Regions 2014-2019
Figure Global Influenza Medication Sales Market Share by Regions 2014-2019
Figure 2018 Global Influenza Medication Sales Market Share by Regions
Table Global Influenza Medication Revenue by Regions 2014-2019 (Million US$)
Table Global Influenza Medication Revenue Market Share by Regions 2014-2019
Figure Global Influenza Medication Revenue Market Share by Regions 2014-2019
Figure 2018 Global Influenza Medication Revenue Market Share by Regions
Table Global Influenza Medication Sales by Manufacturers (2014-2019) (K Units)
Table Global Influenza Medication Sales Share by Manufacturers (2014-2019)
Figure Global Influenza Medication Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Influenza Medication Revenue by Manufacturers (2014-2019) (Million USD)
Table Influenza Medication Revenue Share by Manufacturers (2014-2019)
Figure Influenza Medication Value Share by Manufacturers in 2018
Table Key Manufacturers Influenza Medication Price (2014-2019) (USD/Unit)
Table Influenza Medication Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Influenza Medication Product Type
Table Date of International Manufacturers Enter into Influenza Medication Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Influenza Medication Sales by Product (2014-2019) (K Units)
Table Global Influenza Medication Sales Share by Product (2014-2019)
Figure Global Influenza Medication Sales Market Share by Product (2014-2019)
Figure Global Influenza Medication Sales Market Share by Product in 2018
Table Global Influenza Medication Revenue by Product (2014-2019) (Million US$)
Table Global Influenza Medication Revenue Share by Product (2014-2019)
Figure Global Influenza Medication Revenue Market Share by Product (2014-2019)
Figure Global Influenza Medication Revenue Market Share by Product in 2018
Table Influenza Medication Price by Product 2014-2019 (USD/Unit)
Table Global Influenza Medication Sales by End User (2014-2019) (K Units)
Table Global Influenza Medication Sales Share by End User (2014-2019)
Figure Global Sales Influenza Medication Market Share by End User (2014-2019)
Figure Global Sales Influenza Medication Market Share by End User in 2018
Figure North America Influenza Medication Sales Growth Rate 2014-2019 (K Units)
Figure North America Influenza Medication Revenue Growth Rate 2014-2019 (Million US$)
Table North America Influenza Medication Sales by Countries (2014-2019) (K Units)
Table North America Influenza Medication Sales Market Share by Countries (2014-2019)
Figure 2018 North America Influenza Medication Sales Market Share by Countries
Table North America Influenza Medication Revenue by Countries (2014-2019) (Million US$)
Table North America Influenza Medication Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Influenza Medication Revenue Market Share by Countries
Figure United States Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure United States Influenza Medication Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Canada Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Table North America Influenza Medication Sales by Product (2014-2019) (K Units)
Table North America Influenza Medication Sales Market Share by Product (2014-2019)
Figure 2018 North America Influenza Medication Market Share by Product
Table North America Influenza Medication Sales by End User (2014-2019) (K Units)
Table North America Influenza Medication Sales Market Share by End User (2014-2019)
Figure 2018 North America Influenza Medication Market Share by End User
Figure Europe Influenza Medication Sales Growth Rate 2014-2019 (K Units)
Figure Europe Influenza Medication Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Influenza Medication Sales by Countries (2014-2019) (K Units)
Table Europe Influenza Medication Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Influenza Medication Sales Market Share by Countries
Table Europe Influenza Medication Revenue by Countries (2014-2019) (Million US$)
Table Europe Influenza Medication Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Influenza Medication Revenue Market Share by Countries
Figure Germany Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Germany Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure France Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure France Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure UK Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Italy Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Russia Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Influenza Medication Sales by Product (2014-2019) (K Units)
Table Europe Influenza Medication Sales Market Share by Product (2014-2019)
Figure 2018 Europe Influenza Medication Market Share by Product
Table Europe Influenza Medication Sales by End User (2014-2019) (K Units)
Table Europe Influenza Medication Sales Market Share by End User (2014-2019)
Figure 2018 Europe Influenza Medication Market Share by End User
Figure Asia Pacific Influenza Medication Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Influenza Medication Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Influenza Medication Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Influenza Medication Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Influenza Medication Sales Market Share by Countries
Table Asia Pacific Influenza Medication Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Influenza Medication Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Influenza Medication Revenue Market Share by Countries
Figure China Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure China Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Japan Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Korea Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure India Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure India Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Australia Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Influenza Medication Sales by Product (2014-2019) (K Units)
Table Asia Pacific Influenza Medication Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Influenza Medication Market Share by Product
Table Asia Pacific Influenza Medication Sales by End User (2014-2019) (K Units)
Table Asia Pacific Influenza Medication Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Influenza Medication Market Share by End User
Figure Central & South America Influenza Medication Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Influenza Medication Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Influenza Medication Sales by Countries (2014-2019) (K Units)
Table Central & South America Influenza Medication Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Influenza Medication Sales Market Share by Countries
Table Central & South America Influenza Medication Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Influenza Medication Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Influenza Medication Revenue Market Share by Countries
Figure Brazil Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Influenza Medication Sales by Product (2014-2019) (K Units)
Table Central & South America Influenza Medication Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Influenza Medication Market Share by Product
Table Central & South America Influenza Medication Sales by End User (2014-2019) (K Units)
Table Central & South America Influenza Medication Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Influenza Medication Market Share by End User
Figure Middle East and Africa Influenza Medication Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Influenza Medication Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Influenza Medication Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Influenza Medication Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Influenza Medication Sales Market Share by Countries
Table Middle East and Africa Influenza Medication Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Influenza Medication Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Influenza Medication Revenue Market Share by Countries
Figure GCC Countries Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Influenza Medication Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Influenza Medication Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Influenza Medication Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Influenza Medication Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Influenza Medication Market Share by Product
Table Middle East and Africa Influenza Medication Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Influenza Medication Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Influenza Medication Market Share by End User
Table Daiichi Sankyo Company Company Details
Table Daiichi Sankyo Company Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Daiichi Sankyo Company Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Natco Pharma Company Details
Table Natco Pharma Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Natco Pharma Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Sandoz International GmbH (Novartis AG) Company Details
Table Sandoz International GmbH (Novartis AG) Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sandoz International GmbH (Novartis AG) Recent Development
Table Sun Pharmaceutical Industries Company Details
Table Sun Pharmaceutical Industries Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sun Pharmaceutical Industries Recent Development
Table Mylan Company Details
Table Mylan Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mylan Recent Development
Table Global Influenza Medication Sales Forecast by Regions 2019-2025 (K Units)
Table Global Influenza Medication Sales Market Share Forecast by Regions 2019-2025
Table Global Influenza Medication Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Influenza Medication Revenue Market Share Forecast by Regions 2019-2025
Table Global Influenza Medication Sales Forecast by Product 2019-2025 (K Units)
Table Global Influenza Medication Sales Market Share Forecast by Product 2019-2025
Table Global Influenza Medication Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Influenza Medication Revenue Market Share Forecast by Product 2019-2025
Table Global Influenza Medication Sales Forecast by End User 2019-2025 (K Units)
Table Global Influenza Medication Sales Market Share Forecast by End User 2019-2025
Figure North America Influenza Medication Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Influenza Medication Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Influenza Medication Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Influenza Medication Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Influenza Medication Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Influenza Medication Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Influenza Medication Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Influenza Medication Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Influenza Medication Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Influenza Medication Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Influenza Medication Value Chain
Table Influenza Medication Customers List
Table Influenza Medication Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Electronic files(PDF) of market research reports will be dispatched within 12 to 24 hours. (Mon-Fri IST)

Select License Type

Need Help?
+
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.